Conference News Conference News Daily digests from key neurology conferences, written by on-site medical journalists. Published: Apr 27, 2020

Fingolimod vs natalizumab: how do they affect slowly expanding lesions in multiple sclerosis?

A new study has compared the impact of two therapies on slowly expanding lesions (SELs), a potential biomarker of smoldering inflammation in patients with relapsing-remitting multiple sclerosis (MS).